Survival outcomes of acute normovolemic hemodilution in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center Team Ovary study
- 17 November 2020
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 160 (1), 51-55
- https://doi.org/10.1016/j.ygyno.2020.10.042
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
This publication has 27 references indexed in Scilit:
- A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancerGynecologic Oncology, 2014
- Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusionsBritish Journal of Anaesthesia, 2013
- Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastasesAnnals of Surgical Oncology, 2013
- Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusionPublished by Wiley ,2011
- Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusionPublished by Wiley ,2011
- Advanced cytoreductive surgery: American perspectiveGynecologic Oncology, 2009
- Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigmGynecologic Oncology, 2009
- A Prospective Randomized Trial of Acute Normovolemic Hemodilution Compared to Standard Intraoperative Management in Patients Undergoing Major Hepatic ResectionAnnals of Surgery, 2008
- Prospective randomized controlled trial of acute normovolaemic haemodilution in major gastrointestinal surgeryBritish Journal of Anaesthesia, 2004
- Erythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trialsTransfusion Medicine, 1998